Ola Soderquist - 31 Dec 2021 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CFO, 10%+ Owner
Signature
/s/ Ola Soderquist
Issuer symbol
BIXT
Transactions as of
31 Dec 2021
Transactions value $
$38,125
Form type
5
Filing time
28 Jan 2022, 13:20:11 UTC
Previous filing
18 Jan 2022
Next filing
07 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT Common Award $54,672 +227,800 +1.13% $0.24 20,363,100 15 Jan 2021 Direct
transaction BIXT Common Award $386,618 +2,973,988 +14.6% $0.13 23,337,088 04 Jun 2021 Direct
transaction BIXT Common Gift -$441,846 -3,201,788 -13.72% $0.138 20,135,300 18 Nov 2021 Direct F1
transaction BIXT Common Award $2,681 +1,340,749 +6.66% $0.002* 21,476,049 03 Dec 2021 by NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT Warrant Award $36,000 +100,000 $0.36 100,000 02 May 2021 Common 100,000 $2 by NDPD Pharma, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares returned to Company's treasury
F2 The warrant agreement includes provisions for dilutive issuance and cash-less exercise